Aura Biosciences (AURA) Interest Expenses (2020 - 2026)

Aura Biosciences' Interest Expenses history runs 7 years deep, the most recent figure standing at $23.5 million for Q1 2026.

• Quarterly Interest Expenses rose 805.47% year-over-year to $23.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.5 million (up 805.47% YoY) and the FY2025 annual result came in at $3.3 million, down 59.02% from the prior year.
• Interest Expenses was $23.5 million for Q1 2026 at Aura Biosciences, up from $841000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $61.5 million in Q1 2022 and bottomed at $768000.0 in Q4 2022.
• A 5-year average of $16.9 million and a median of $11.5 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses jumped 69777.27% — and 2023, when it sank 79.39%.
• Aura Biosciences' Interest Expenses stood at $768000.0 in 2022, then rose by 3.26% to $793000.0 in 2023, then climbed by 3.03% to $817000.0 in 2024, then grew by 2.94% to $841000.0 in 2025, then soared by 2695.01% to $23.5 million in 2026.
• Business Quant data shows AURA's Interest Expenses at $23.5 million in Q1 2026, $841000.0 in Q4 2025, and $7.4 million in Q3 2025.